 Inhibition platelet GPIIb/IIIa binding serum factors studies immune complexes platelet antibodies patients hemophilia immune thrombocytopenic purpura human immunodeficiency virus-related immune thrombocytopenic purpura systemic lupus erythematosus conditions vitro binding platelet glycoprotein IIb/IIIa GPIIb/IIIa results serum inhibitors binding enzyme-linked immunosorbent assay platelet extract fibrinogen-coated microtiter plate hours incubation anti-GPIIb/IIIa monoclonal antibody hours plate peroxidase-conjugated anti-mouse IgG color development binding calcium-dependent binding fibrinogen anti-fibrinogen antibody Reduction dissociation GPIIb/IIIa total loss ability Platelet extracts patients hemophilia decreased binding control platelet extract extract patient Glanzmann thrombasthenia binding enzyme-linked immunosorbent serum inhibitors GPIIb/IIIa hemophilia immune thrombocytopenic purpura human immunodeficiency virus-related immune thrombocytopenic purpura systemic lupus erythematosus serum samples patients inhibition serum polyethylene glycol precipitation immune complexes CICs inhibition supernatants CIC precipitates inhibition CICs major role inhibition GPIIb/IIIa evidence CIC-mediated impaired GPIIb/IIIa binding hemophilia HIV-ITP SLE